|
BICD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.15339995729624E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.09939962583883E-10 |
| Normal-vs-Stage2 |
6.461400E-03 |
| Normal-vs-Stage3 |
1.024940E-03 |
| Normal-vs-Stage4 |
1.038980E-04 |
| Stage1-vs-Stage2 |
1.901400E-01 |
| Stage1-vs-Stage3 |
3.920200E-03 |
| Stage1-vs-Stage4 |
2.637800E-01 |
| Stage2-vs-Stage3 |
5.766600E-01 |
| Stage2-vs-Stage4 |
6.880400E-01 |
| Stage3-vs-Stage4 |
2.474200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.15279999277374E-09 |
| Normal-vs-AfricanAmerican |
1.418010E-03 |
| Normal-vs-Asian |
2.971500E-04 |
| Caucasian-vs-AfricanAmerican |
1.481820E-01 |
| Caucasian-vs-Asian |
9.969800E-01 |
| AfricanAmerican-vs-Asian |
1.804620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.585500E-04 |
| Normal-vs-Female |
2.85560020074627E-10 |
| Male-vs-Female |
2.660400E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.12169956551145E-10 |
| Normal-vs-Age(41-60Yrs) |
9.3863999994781E-07 |
| Normal-vs-Age(61-80Yrs) |
2.795200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.924200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.614100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.215830E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.190400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.627230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.322000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.787000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.110000E-02 |
| Classical-VS-Follicular |
1.62303999999835E-05 |
| Classical-VS-Other |
5.202600E-01 |
| Classical-VS-Normal |
9.07240949032939E-12 |
| Tall-VS-Follicular |
1.354980E-01 |
| Tall-VS-Other |
7.716200E-01 |
| Tall-VS-Normal |
1.143940E-03 |
| Follicular-VS-Other |
4.257600E-01 |
| Follicular-VS-Normal |
9.730400E-02 |
| Other-VS-Normal |
3.818200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.445800E-04 |
| Normal-vs-N1 |
6.20459999999268E-05 |
| N0-vs-N1 |
9.612400E-02 |
|
|
